Skip Navigation LinksHome > December 15, 2011 - Volume 58 - Issue 5 > Improved Viral Suppression After Treatment Optimization in H...
JAIDS Journal of Acquired Immune Deficiency Syndromes:
doi: 10.1097/QAI.0b013e3182364513
Brief Report: Basic and Translational Science

Improved Viral Suppression After Treatment Optimization in HIV-Infected Patients With Persistent Low-Level Viremia

McConnell, Michael J. MD, PhD*; Mier-Mota, Julian BS*; Flor-Parra, Fernando BS*; Martinez-Fernandez, Francisco J.*; Lopez-Cortes, Luis F. MD, PhD*; Viciana, Pompeyo MD, PhD*; Fernandez-Cuenca, Felipe PhD; Perez-Romero, Pilar PhD*

Supplemental Author Material
Collapse Box


Abstract: Optimizing treatment for patients with persistent low-level viremia is complicated because most genotyping tests are validated for viral loads >1000 copies per milliliter. In this study, genotypes of 92 treatment-experienced patients with persistent low-level viremia were determined using an in-house assay. Based on the resistance profiles obtained from genotyping and patient pharmacologic history, patients were either maintained on their antiviral regimen (n = 51) or received an optimized regimen (n = 41). In the group receiving optimized treatment, undetectable viral loads were achieved in 73.2% at 6 months and at 90.2% at 1 year, indicating that treatment guided by genotyping of patients with low-level viremia is effective in achieving viral suppression.

© 2011 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.